hypochlorous acid has been researched along with Sclerosis, Systemic in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, S; Chadli, L; Chomel, A; Courtade-Gaïani, S; De Ceuninck, F; Desvaux, E; Elouej, S; Fould, B; Guerrier, T; Hubert, S; Jendoubi, M; Launay, D; Le Gall, M; Levasseur, F; Licznar, A; Neau, B; Nguyen, TQ; Nony, E; Ortega-Ferreira, C; Provost, N; Robin, G; Saint-Paul, J; Soret, P; Speca, S; Verdier, J | 1 |
| Colmegna, I; Fraser, R; Fujii, U; Joy, S; Martin, JG; Morozan, A; Watters, K | 1 |
| Chen, W; Du, Q; Meng, M; Tan, J; Wang, K; Wang, N; Xie, B; Zhu, H | 1 |
| Ballerie, A; Batteux, F; Fardel, O; Jego, P; Jeljeli, M; Jouneau, S; Lecureur, V; Lelong, M; Lescoat, A; Morzadec, C; Piquet-Pellorce, C; Vernhet, L | 1 |
| Guilpain, P; Jorgensen, C; Lai-Kee-Him, J; Maria, ATJ; Maumus, M; Noël, D; Rozier, P; Toupet, K | 1 |
| Altavilla, D; Atteritano, M; Bagnato, G; Bitto, A; Cinquegrani, M; Irrera, N; Pizzino, G; Roberts, W; Saitta, A; Sangari, D; Squadrito, F | 1 |
| Anwar, A; Batteux, F; Chéreau, C; Eggleton, P; Jacob, C; Jamier, V; Kavian, N; Marut, W; Nicco, C; Servettaz, A; Weill, B; Winyard, PG | 1 |
| Batteux, F; Chéreau, C; Chimini, G; Galland, F; Guilpain, P; Kavian, N; Lemaréchal, H; Marut, W; Naquet, P; Nicco, C; Servettaz, A; Weill, B | 1 |
| Batteux, F; Bei, Y; Chéreau, C; Dinh-Xuan, AT; Duong-Quy, S; Hua-Huy, T; Le-Dong, NN; Nicco, C; Rivière, S; Tiev, KP | 1 |
| Altavilla, D; Bagnato, GF; Bagnato, GL; Bitto, A; Irrera, N; Minutoli, L; Pizzino, G; Roberts, WN; Russo, G; Saitta, A; Squadrito, F | 1 |
| Batteux, F; Bei, Y; Chéreau, C; Dinh-Xuan, AT; Duong-Quy, S; Hua-Huy, T; Le-Dong, NN; Nicco, C; Tiev, KP | 1 |
| Böhm, M; Haub, J; Lorenz, N; Ook, KY; Raker, VK; Schmidt, T; Schuppan, D; Stegemann, A; Steinbrink, K | 1 |
| Batteux, F; Cerles, O; Chéreau, C; Kavian, N; Morin, F; Nicco, C | 1 |
| Batteux, F; Chéreau, C; Deveaux, V; Kavian, N; Lotersztajn, S; Nicco, C; Servettaz, A; Wang, A; Weill, B; Zimmer, A | 1 |
| Batteux, F; Kavian, N; Servettaz, A | 1 |
| Ba, LA; Batteux, F; Chéreau, C; Doering, M; Jacob, C; Kavian, N; Marut, WK; Nicco, C; Servettaz, A; Weill, B | 1 |
| Batteux, F; Chéreau, C; Dinh-Xuan, AT; Hua-Huy, T; Kavian, N; Marut, W; Nicco, C; Servettaz, A; Weill, B | 1 |
1 review(s) available for hypochlorous acid and Sclerosis, Systemic
| Article | Year |
|---|---|
New insights on chemically induced animal models of systemic sclerosis.
Topics: Animals; Autoimmunity; Bleomycin; Disease Models, Animal; Fibrosis; Humans; Hypochlorous Acid; Inflammation; Mice; Reactive Oxygen Species; Scleroderma, Systemic | 2011 |
16 other study(ies) available for hypochlorous acid and Sclerosis, Systemic
| Article | Year |
|---|---|
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.
Topics: Animals; Antibodies, Monoclonal; Cross-Sectional Studies; Disease Models, Animal; Galectin 3; Hypochlorous Acid; Mice; Scleroderma, Systemic | 2023 |
Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
Topics: Animals; Bleomycin; Disease Models, Animal; Fibrosis; Hypochlorous Acid; Lung; Lung Diseases, Interstitial; Mice; NF-E2-Related Factor 2; Pulmonary Fibrosis; Scleroderma, Systemic; Skin | 2023 |
The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Topics: Animals; Disease Models, Animal; Fibrosis; Hypochlorous Acid; Lung; Mice; Mice, Inbred BALB C; Oxidants; Scleroderma, Systemic; Skin | 2019 |
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Chemokine CXCL13; Female; Gene Expression Regulation; Hypochlorous Acid; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Lung; Lung Diseases, Interstitial; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Nitriles; Piperidines; Primary Cell Culture; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Immunologic; Scleroderma, Systemic; Suppressor of Cytokine Signaling 3 Protein | 2020 |
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p.
Topics: Animals; Apoptosis; Disease Models, Animal; DNA Methylation; DNA Methyltransferase 3A; Extracellular Vesicles; Female; Gene Expression Regulation; Humans; Hypochlorous Acid; Mesenchymal Stem Cells; Mice; MicroRNAs; Receptor, Platelet-Derived Growth Factor beta; Scleroderma, Systemic | 2021 |
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
Topics: Actins; Animals; Antithyroid Agents; Blotting, Western; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Fibrosis; Hypochlorous Acid; Hypothyroidism; Immunohistochemistry; Mice; Mice, Inbred BALB C; Muscle, Smooth; Oxidants; Propylthiouracil; Pulmonary Fibrosis; Random Allocation; ras Proteins; Scleroderma, Systemic; Skin; Thyrotropin; Thyroxine; Triiodothyronine; Vascular Endothelial Growth Factor A | 2013 |
The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse.
Topics: Actins; Animals; Apoptosis; Autoantibodies; Cell Proliferation; Cells, Cultured; Collagen; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Female; Fibroblasts; Fibrosis; Flow Cytometry; Hydrogen Peroxide; Hypochlorous Acid; Interleukin-13; Interleukin-4; Lung; Lymphocytes; Mice; Mice, Inbred BALB C; Scleroderma, Systemic; Skin; Smad Proteins; Sulfides | 2013 |
Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter 1; Bleomycin; Cell-Derived Microparticles; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Female; Fibroblasts; Homeostasis; Hypochlorous Acid; In Vitro Techniques; Injections, Intradermal; Mice; Mice, Inbred BALB C; Mice, Knockout; Oxidative Stress; Pantetheine; Scleroderma, Systemic; Treatment Outcome | 2015 |
Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis.
Topics: Animals; Bleomycin; Breath Tests; Disease Models, Animal; Female; Hypochlorous Acid; Mice; Mice, Inbred C57BL; Nitric Oxide; Pulmonary Fibrosis; Scleroderma, Systemic; Skin | 2015 |
Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis.
Topics: Animals; Aorta; Carotid Intima-Media Thickness; Cell Differentiation; Collagen; Disease Models, Animal; Gene Expression Regulation; Humans; Hypochlorous Acid; Kidney; Mice; Myofibroblasts; Platelet Endothelial Cell Adhesion Molecule-1; Reactive Oxygen Species; Scleroderma, Systemic; Simvastatin; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Disease Models, Animal; Female; Hypochlorous Acid; Lung; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Pneumonia; Pulmonary Fibrosis; rho-Associated Kinases; Scleroderma, Systemic; Skin; Smad2 Protein; Smad3 Protein; Tyrosine | 2016 |
Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis.
Topics: Animals; Bleomycin; Disease Models, Animal; Female; Fibrosis; Hypochlorous Acid; Mice, Inbred C57BL; Myeloid Cells; Scleroderma, Systemic; Skin | 2016 |
Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
Topics: Animals; Anthelmintics; Autoantibodies; B-Lymphocytes; Bleomycin; Cells, Cultured; Cytokines; Disease Models, Animal; DNA Topoisomerases, Type I; Female; Fibrosis; Humans; Hypochlorous Acid; Lung; Mice; Mice, Inbred BALB C; Niclosamide; Reactive Oxygen Species; Scleroderma, Systemic; Signal Transduction; Skin; T-Lymphocytes | 2016 |
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.
Topics: Analgesics; Animals; Autoantibodies; Autoimmunity; Benzoxazines; Cannabinoids; Cell Proliferation; Cells, Cultured; Disease Models, Animal; DNA Topoisomerases, Type I; Female; Fibroblasts; Fibrosis; Humans; Hypochlorous Acid; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Oxidants; Random Allocation; Receptor, Cannabinoid, CB2; Scleroderma, Systemic; Signal Transduction; Skin | 2010 |
The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.
Topics: Actins; Animals; Autoantibodies; Cells, Cultured; Disease Models, Animal; DNA Topoisomerases, Type I; Female; Fibroblasts; Fibrosis; Glutathione; Hydrogen Peroxide; Hypochlorous Acid; In Vitro Techniques; Mice; Mice, Inbred BALB C; Naphthoquinones; Nitric Oxide; Organometallic Compounds; Reactive Oxygen Species; Scleroderma, Systemic; Skin; Tellurium | 2012 |
Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Biphenyl Compounds; Breath Tests; Disease Models, Animal; Female; Fibrosis; Hypochlorous Acid; Injections, Intradermal; Irbesartan; Lung; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidants; Pulmonary Fibrosis; Scleroderma, Systemic; Skin; Tetrazoles; Tyrosine | 2013 |